These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21530278)

  • 21. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
    Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double click reaction for the acquisition of a highly potent and selective mPTPB inhibitor.
    He R; Yu Z; He Y; Zeng LF; Xu J; Wu L; Gunawan AM; Wang L; Jiang ZX; Zhang ZY
    ChemMedChem; 2010 Dec; 5(12):2051-6. PubMed ID: 20957718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine phosphatase MptpA of Mycobacterium tuberculosis inhibits phagocytosis and increases actin polymerization in macrophages.
    Castandet J; Prost JF; Peyron P; Astarie-Dequeker C; Anes E; Cozzone AJ; Griffiths G; Maridonneau-Parini I
    Res Microbiol; 2005 Dec; 156(10):1005-13. PubMed ID: 16085396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).
    Manos-Turvey A; Bulloch EM; Rutledge PJ; Baker EN; Lott JS; Payne RJ
    ChemMedChem; 2010 Jul; 5(7):1067-79. PubMed ID: 20512795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brunsvicamides A-C: sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity.
    Müller D; Krick A; Kehraus S; Mehner C; Hart M; Küpper FC; Saxena K; Prinz H; Schwalbe H; Janning P; Waldmann H; König GM
    J Med Chem; 2006 Aug; 49(16):4871-8. PubMed ID: 16884299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photoactivated enediynes as targeted antitumoral agents: efficient routes to antibody and gold nanoparticle conjugates.
    Falcone D; Li J; Kale A; Jones GB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):934-7. PubMed ID: 18182287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzofused N-substituted cyclic enediynes: activation and DNA-cleavage potential.
    Basak A; Kar M
    Bioorg Med Chem; 2008 Apr; 16(8):4532-7. PubMed ID: 18316195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
    Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
    Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor.
    Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bergman cyclization of acyclic amino acid derived enediynes leads to the formation of 2,3-dihydrobenzo[f]isoindoles.
    Gredicak M; Matanović I; Zimmermann B; Jerić I
    J Org Chem; 2010 Sep; 75(18):6219-28. PubMed ID: 20718455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and aromatisation of cyclic enediyne-containing amino acids.
    Kaiser J; van Esseveldt BC; Segers MJ; van Delft FL; Smits JM; Butterworth S; Rutjes FP
    Org Biomol Chem; 2009 Feb; 7(4):695-705. PubMed ID: 19194585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
    Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
    Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.
    Chiaradia LD; Mascarello A; Purificação M; Vernal J; Cordeiro MN; Zenteno ME; Villarino A; Nunes RJ; Yunes RA; Terenzi H
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6227-30. PubMed ID: 18930396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
    Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
    FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative Reactivity of Benzothiophene-Fused Enediynes in the Bergman Cyclization.
    Lyapunova AG; Danilkina NA; Rumyantsev AM; Khlebnikov AF; Chislov MV; Starova GL; Sambuk EV; Govdi AI; Bräse S; Balova IA
    J Org Chem; 2018 Mar; 83(5):2788-2801. PubMed ID: 29402088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.
    Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site.
    Manos-Turvey A; Cergol KM; Salam NK; Bulloch EM; Chi G; Pang A; Britton WJ; West NP; Baker EN; Lott JS; Payne RJ
    Org Biomol Chem; 2012 Dec; 10(46):9223-36. PubMed ID: 23108268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The apo-structure of the low molecular weight protein-tyrosine phosphatase A (MptpA) from Mycobacterium tuberculosis allows for better target-specific drug development.
    Stehle T; Sreeramulu S; Löhr F; Richter C; Saxena K; Jonker HR; Schwalbe H
    J Biol Chem; 2012 Oct; 287(41):34569-82. PubMed ID: 22888002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
    Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
    J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ortho effect in the Bergman cyclization: comparison of experimental approaches and dissection of cycloaromatization kinetics.
    Zeidan TA; Kovalenko SV; Manoharan M; Alabugin IV
    J Org Chem; 2006 Feb; 71(3):962-75. PubMed ID: 16438508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.